In:
Antiviral Therapy, SAGE Publications, Vol. 16, No. 4 ( 2011-05), p. 565-575
Abstract:
Data are inconclusive whether treatment with HAART induces functional recovery of HIV-specific T-cells. Since the introduction of HAART, a marked decrease of cytomegalovirus (CMV) disease – for which untreated HIV-infected individuals are at increased risk – is observed, suggesting that this treatment influences CMV-specific T-cell immunity. Methods To study potential functional recovery of HIV-and CMV-specific T-cells, CD4 + and CD8 + T-cell responses were measured longitudinally after in vitro expansion using gag, pp65 and IE1 peptide pools, during HIV infection and after long-term HAART. Results HIV-specific T-cell function, measured by interferon (IFN)-γ production, was low after initiation of HAART. Interestingly, the cytotoxic function – measured by CD107a expression – of these T-cells temporarily increased after start of treatment, suggesting some functional recovery. The pp65-specific CD8 + T-cell responses tended to decrease during HIV infection, whereas pp65-specific CD4 + T-cell responses decreased upon treatment with HAART. Both pp65-specific CD4 + and CD8 + T-cell responses were low after initiation of HAART compared to healthy controls. By contrast, IE1-specific CD4 + T-cell responses increased during the course of HIV infection. After initiation of HAART, IE1-specific T-cell responses decreased, but IE1-specific CD8 + T-cells seemed increased compared to healthy controls. Conclusions This study suggests that HIV-infection leads to an altered CMV biology, affecting pp65- and IE1-specific T-cell responses in a different way, which is not restored by treatment with long-term HAART.
Type of Medium:
Online Resource
ISSN:
1359-6535
,
2040-2058
Language:
English
Publisher:
SAGE Publications
Publication Date:
2011
detail.hit.zdb_id:
2118396-X
SSG:
15,3
Permalink
